Corporate
Description
  • Value proposition

    We aspire to be the premier research-intensive biopharmaceutical company.

    At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Entity interactions BETA
Entity TypeTweets Articles
Dignio Dignio
healthtech, Hospitals and Health Care
Other

29 Sep 2022


HSEVEN - H7 HSEVEN - H7
Venture Capital and Private Equity Principals
Other

30 Sep 2022


One Health Trust One Health Trust
healthtech, Research Services
Other

3 Oct 2022


American Chamber of Commerce in Poland American Chamber of Commerce in Poland
e-commerce, Non-profit Organizations
Other

11 May 2017

17 Oct 2022



Aquaculture North America Aquaculture North America
Fisheries
Other

21 Oct 2022


Beat Beat Beat Beat
Advertising Services
Other

31 Oct 2022


Business Reporter Business Reporter
Book and Periodical Publishing
Other

2 Nov 2022


Stichting tegen Kanker - Fondation contre le Cancer Stichting tegen Kanker - Fondation contre le Cancer
healthtech, Civic and Social Organizations
Other

12 Nov 2022


Frontiers Health Frontiers Health
Events Services, healthtech
Other

16 Nov 2022


Braithwaite Consultants | Irish R&D Tax Credit Specialists Braithwaite Consultants | Irish R&D Tax Credit Specialists
fintech, Financial Services
Other

17 Nov 2022


Radars
Loading...